Business & Tech
Mansfield's Covidien Buying Medical Company
Covidien in Mansfield buying California medical company.
Mansfield's Covidien announced on Sunday that they will be purchasing a medical technology company.
The company, CV Ingenuity, provides treatment for peripheral artial disease caused by blood vessel abnormalities.
The company, based in Fremont California, has been working on a drug-coated balloon platform that used a rapid release systems.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
"CV Ingenuity offers a robust DCB portfolio, and offering a DCB technology is something that we believe is necessary to continue to improve care for patients suffering from PAD, as well as ensuring we are a full line partner with our customers today and into the future," said Stacy Enxing Seng, president of Covidien Vascular Therapies.
Covidien said in a statement Food and Drug Administration approval will likely come for the treatment method in 2017.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Covidien also stated that they will be spending over $50 million in the next two years to finance development.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.